[1]Bodnar,AliceL.;Cortes-Burgos,LuzA.;Cook,KarenK.;Dinh,DacM.;Groppi,VincentE.;Hajos,Mihaly;Higdon,NicoleR.;Hoffmann,WilliamE.;Hurst,RaymondS.;Myers,JasonK.;Rogers,BruceN.;Wall,TheronM.;Wolfe,MarkL.;Wong,Erik[JournalofMedicinalChemistry,2005,vol.48,#4,p.905-908]
[1]CurrentPatentAssignee:SANOFI-US5206246,1993,A
[1]CurrentPatentAssignee:SANOFI-US5206246,1993,A
Title: Bodnar AL, et al. Discovery and structure-activity relationship of quinuclidine benzamides as agonists of alpha7 nicotinic acetylcholine receptors. J Med Chem. 2005 Feb 24;48(4):905-8.
Title: Dong Jun Yu, et al. Effect of ischemic preconditioning combined with α7 nAchR agonists on limb ischemia-reperfusion lung injury in rat. Biomed Res. 2017; Special Issue: ISSN 0970.
Title: Li F, et al. The protective effect of PNU-282987, a selective α7 nicotinic acetylcholine receptor agonist, on the hepatic ischemia-reperfusion injury is associated with the inhibition of high-mobility group box 1 protein expression and nuclear factor κB activation in mice. Shock. 2013 Feb;39(2):197-203.
Title: Stuckenholz V, et al. The α7 nAChR agonist PNU-282987 reduces inflammation and MPTP-induced nigral dopaminergic cell loss in mice. J Parkinsons Dis. 2013;3(2):161-72.
Title: Mesa-Gresa P, et al. Behavioral effects of different enriched environments in mice treated with the cholinergic agonist PNU-282987. Behav Processes. 2014 Mar;103:117-24.
